{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:23:02Z","timestamp":1782400982447,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.eimc.2017.04.007","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T00:31:58Z","timestamp":1498782718000},"page":"517-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Manejo terap\u00e9utico de la fiebre hemorr\u00e1gica de Crimea-Congo"],"prefix":"10.1016","volume":"36","author":[{"given":"Fernando","family":"de la Calle-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn-Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mora-Rillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Arsuaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"D\u00edaz-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2017.04.007_bib0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coviro.2016.08.005","article-title":"Transmission and evolution of tick-borne viruses","volume":"21","author":"Brackney","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.eimc.2017.04.007_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coviro.2012.03.001","article-title":"Crimean\u2013Congo hemorrhagic fever virus: new outbreaks, new discoveries","volume":"2","author":"Erg\u00f6n\u00fcl","year":"2012","journal-title":"Curr Opin Virol."},{"key":"10.1016\/j.eimc.2017.04.007_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3201\/eid1801.111040","article-title":"Crimean-Congo hemorrhagic fever virus in ticks, southwestern Europe, 2010","volume":"18","author":"Estrada-Pe\u00f1a","year":"2012","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0235","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1615162","article-title":"Autochthonous Crimean-Congo hemorrhagic fever in Spain","author":"Negredo","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2017.04.007_bib0240","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-3542(04)00163-9","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Research"},{"key":"10.1016\/j.eimc.2017.04.007_bib0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Erg\u00f6n\u00fcl","year":"2006","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0250","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2015.11.024","article-title":"Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study","volume":"22","author":"Leblebicioglu","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.eimc.2017.04.007_bib0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijid.2014.12.047","article-title":"Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. International Journal of Infectious Diseases","volume":"33","author":"Pshenichnaya","year":"2015","journal-title":"International Society for Infectious Diseases"},{"key":"10.1016\/j.eimc.2017.04.007_bib0260","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s15010-016-0923-x","article-title":"Crimean-Congo haemorrhagic fever: transmission to visitors and healthcare workers","volume":"44","author":"Yildirmak","year":"2016","journal-title":"Infection."},{"key":"10.1016\/j.eimc.2017.04.007_bib0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.antiviral.2016.06.011","article-title":"Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever","volume":"132","author":"Akinci","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.eimc.2017.04.007_bib0270","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1309\/LMN1P2FRZ7BKZSCO","article-title":"Crimean-Congo hemorrhagic fever","volume":"46","author":"Shayan","year":"2015","journal-title":"Lab Med Summer"},{"key":"10.1016\/j.eimc.2017.04.007_bib0275","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2015.12.003","article-title":"Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges","volume":"126","author":"Leblebicioglu","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.eimc.2017.04.007_bib0285","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(09)70070-2","article-title":"Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease","volume":"9","author":"Brouqui","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(08)70304-9","article-title":"Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases","volume":"9","author":"Bannister","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0295","doi-asserted-by":"crossref","first-page":"e1046","DOI":"10.1016\/j.ijid.2013.05.005","article-title":"Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus","volume":"17","author":"Gozel","year":"2013","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0300","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/vbz.2011.0896","article-title":"Case management and supportive treatment for patients with Crimean-Congo Hemorrhagic Fever","volume":"12","author":"Leblebicioglu","year":"2012","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0305","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jhin.2016.02.023","article-title":"Managing the risk of viral haemorrhagic fever transmission in a non-high-level intensive care unit: experiences from a case of Crimean-Congo haemorrhagic fever in Scotland","volume":"93","author":"Roy","year":"2016","journal-title":"J Hosp Infect."},{"key":"10.1016\/j.eimc.2017.04.007_bib0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2007.11.002","article-title":"Treatment of Crimean-Congo hemorrhagic fever","volume":"78","author":"Erg\u00f6n\u00fcl","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eimc.2017.04.007_bib0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0049475513486642","article-title":"Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia","volume":"43","author":"Sharifi-Mood","year":"2013","journal-title":"Trop Doct."},{"key":"10.1016\/j.eimc.2017.04.007_bib0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1258\/td.2009.090069","article-title":"High-dose methylprednisolone in children with Crimean- Congo haemorrhagic fever","volume":"40","author":"Dilber","year":"2010","journal-title":"Trop Doct."},{"key":"10.1016\/j.eimc.2017.04.007_bib0325","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2017.04.007_bib0330","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer."},{"key":"10.1016\/j.eimc.2017.04.007_bib0335","doi-asserted-by":"crossref","unstructured":"AASLD\/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932\u201354.","DOI":"10.1002\/hep.27950"},{"key":"10.1016\/j.eimc.2017.04.007_bib0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2011.02.010","article-title":"Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies","volume":"90","author":"Keshtkar-Jahromi","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eimc.2017.04.007_bib0345","doi-asserted-by":"crossref","first-page":"e2804","DOI":"10.1371\/journal.pntd.0002804","article-title":"Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever","volume":"8","author":"Oestereich","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0350","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcv.2014.08.029","article-title":"Recent advances in research on Crimean-Congo hemorrhagic fever","volume":"64","author":"Papa","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.eimc.2017.04.007_bib0355","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkr136","article-title":"Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis","volume":"66","author":"Ascioglu","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2017.04.007_bib0360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"10","author":"Soares-Weiser","year":"2010","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2009.11.007","article-title":"The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey","volume":"47","author":"Koksal","year":"2010","journal-title":"J Clin Virol."},{"key":"10.1016\/j.eimc.2017.04.007_bib0370","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1016\/j.ijid.2013.02.030","article-title":"Ribavirin is not effective against Crimean\u2013Congo hemorrhagic fever: observations from the Turkish experience","volume":"17","author":"Ceylan","year":"2013","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0375","unstructured":"Jacob S. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the Front-line Health Worker. \u00a9 World Health Organization 2016 pp. 1\u2013203. [citado 15 Ene 2017]. Disponible en: http:\/\/apps.who.int\/medicinedocs\/documents\/s22501en\/s22501en.pdf"},{"key":"10.1016\/j.eimc.2017.04.007_bib0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijid.2014.08.015","article-title":"The efficacy of ribavirin in Crimean-Congo hemorrhagic fever\u2014randomized trials are urgently needed","volume":"29","author":"Ceylan","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimc.2017.04.007_bib0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/fvl.14.115","article-title":"Therapeutic intervention in Crimean-Congo hemorrhagic fever: where are we now?","volume":"10","author":"Spengler","year":"2015","journal-title":"Future Virol"},{"key":"10.1016\/j.eimc.2017.04.007_bib0390","unstructured":"Application for inclusion of ribavirin in the who model list of essential medicines. ribavirin.doc. The Secretary of the Expert Committee on the Selection and Use of Essential Medicines. Department of Medicines Policy and Standards. World Health Organization. 2006 Nov 7;1\u201331. [citado 15 Ene 2017]. Disponible en: www.who.int\/eml\/expcom\/expcom15\/applications\/newmed\/ribavirin\/ribavirin.pdf"},{"key":"10.1016\/j.eimc.2017.04.007_bib0395","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eimc.2017.04.007_bib0400","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2015.03.005","article-title":"Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules","volume":"118","author":"Ferraris","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.eimc.2017.04.007_bib0405","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7883\/yoken.64.439","article-title":"Prompt administration of crimean-congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR","volume":"64","author":"Kubar","year":"2011","journal-title":"Jpn J Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0410","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0140-6736(90)90906-L","article-title":"Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever","volume":"335","author":"Vassilenko","year":"1990","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2017.04.007_bib0415","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","article-title":"Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins","volume":"79","author":"Bertolotti-Ciarlet","year":"2005","journal-title":"J Virol."},{"issue":"Suppl 4","key":"10.1016\/j.eimc.2017.04.007_bib0420","doi-asserted-by":"crossref","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","article-title":"The clinical pathology of Crimean-Congo hemorrhagic fever","volume":"11","author":"Swanepoel","year":"1989","journal-title":"Rev Infect Dis."},{"key":"10.1016\/j.eimc.2017.04.007_bib0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2016.07.010","article-title":"Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever","volume":"133","author":"Leblebicioglu","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.eimc.2017.04.007_bib0430","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3201\/eid2003.131353","article-title":"Crimean-Congo hemorrhagic fever among health care workers, Turkey","volume":"20","author":"Celikbas","year":"2014","journal-title":"Emerg Infect Dis."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X17301404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X17301404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T05:29:13Z","timestamp":1659158953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X17301404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0213005X17301404"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2017.04.007","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manejo terap\u00e9utico de la fiebre hemorr\u00e1gica de Crimea-Congo","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2017.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}